Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| February 24th, 2025 |
NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 24th, 2025 |
Single Source: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 24th, 2025 |
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 24th, 2025 |
Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required) |
National Institutes of Health |
| February 24th, 2025 |
Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required) |
National Institutes of Health |
| October 14th, 2026 |
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 24th, 2025 |
Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required) |
National Institutes of Health |
| November 15th, 2024 |
USAID Primary Health Care Improvement Program (UPHIP) |
Nigeria USAID-Abuja |
| February 6th, 2025 |
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) |
National Institutes of Health |
| November 27th, 2024 |
USAID Access Miahy |
Madagascar USAID-Antananarivo |
| November 27th, 2024 |
USAID Access Miahy |
Madagascar USAID-Antananarivo |
| November 21st, 2024 |
Advancing Community Health Activity (ACHA) |
Liberia USAID-Monrovia |
| November 1st, 2024 |
Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D and E Centers) (P30 Clinical Trial Optional) |
National Institutes of Health |
| November 1st, 2024 |
Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Disease-Related Dementias Coordinating Center (U24 Clinical Trial Optional) |
National Institutes of Health |
| December 15th, 2024 |
Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 6th, 2025 |
Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Systems) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 22nd, 2026 |
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
National Institutes of Health |
| June 22nd, 2026 |
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
| September 29th, 2027 |
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
|
| December 6th, 2024 |
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| December 6th, 2024 |
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| September 7th, 2027 |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 13th, 2025 |
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| August 18th, 2027 |
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
National Institutes of Health |
| August 18th, 2027 |
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2026 |
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
| March 10th, 2026 |
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
| January 27th, 2025 |
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 15th, 2024 |
Global Health Security (GHS) Activity |
Pakistan USAID Islamabad |
| December 2nd, 2024 |
Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed) |
National Institutes of Health |
| November 25th, 2024 |
National Coordinating Center (NCC) for AHRQs Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U54) |
Agency for Health Care Research and Quality |
| November 25th, 2024 |
National Evaluation Center (NEC) for AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (U19) |
Agency for Health Care Research and Quality |
| January 24th, 2025 |
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) |
National Institutes of Health |
| December 10th, 2024 |
Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 28th, 2025 |
Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS) |
Centers for Disease Control and Prevention - ERA |
| August 18th, 2026 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| June 15th, 2027 |
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 25th, 2027 |
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2025 |
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
National Institutes of Health |
